chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a consumer concerning a 5 year old female relative who was vaccinated at 4 years of age with a dose of MMR II. The reporter stated that a couple weeks after vaccination, she was "staring at the ceiling". Unspecified medical attention was sought and the patient was diagnosed with autism. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Upon internal review, autism was considered to be an other important medical event. No further information is available.
Information has been received from a nurse concerning a teenage patient who was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck). On Approximately 16-FEB-2007, the patient experienced a reaction at the injection site". The nurse reported that the area felt hot and had redness and swelling. There was no product quality complaint. The patient's status was not reported. Additional information has been requested.
she felt different/her brain felt weird; she could not concentrate; a pain wave going to the brain; This is a spontaneous report received from a contactable reporter(s) (Other HCP) for a Pfizer sponsored program. The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Feb2021 (Batch/Lot number: unknown) at the age of 62 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing); "Osteoarthritis" (unspecified if ongoing). There were no concomitant medications. The following information was reported: FEELING ABNORMAL (non-serious) with onset 11Feb2021, outcome "recovered" (11Feb2021), described as "she felt different/her brain felt weird"; DISTURBANCE IN ATTENTION (non-serious) with onset 11Feb2021, outcome "recovered" (11Feb2021), described as "she could not concentrate"; HEADACHE (non-serious) with onset 11Feb2021, outcome "recovered" (11Feb2021), described as "a pain wave going to the brain".  Additional information: The Lot was handwritten so she was unsure if it was EN9810 or CM9810. After the first dose she felt different after 1 hour, it was weird, her brain felt weird, it was like she was coming down with something but it was only effecting the brain, it was a pain wave going to the brain. This had never happened before. It lasted, the weird feeling, lasted for a while but the pain went away, she could not concentrate, it all ended after 2 hours and she was fine after that.    Follow-up attempts completed. No further information is expected. lot/batch number is not available despite the follow-up attempts made.
Pain at injection site began about six hours after vaccination. The next morning had chills, body aches and fatigue and developed a fever of over 101 which broke around 6 p.m.
Pt came in today and wanted me to look at his scab from flu shot. He said he noticed the scab a day after he received the vaccine. The area where the vaccine was administered was reed and had a scab about 1/2 inch long. He stated he did not have a fever.
Initial unsolicited report received from other non-healthcare professional on 03 November 2016. This case involves a 72-year-old female patient who was vaccinated with a dose of Fluzone HD (batch number: UI704AA, expiry date: 17 May 2017, dose not reported) intramuscularly in the left deltoid on 11 Oct 2016. Illness at time of vaccination reported as: unknown and pre-existing physician diagnosed allergies, birth defects and medical conditions include no known allergy. Concomitant medication was not reported. On 18 October 2016, seven days following the vaccination, the patient was complaining of earache and diagnosed as trigeminal neuralgia by a neurologist. On an unspecified date patient required emergency room or doctor visit. Lab data and corrective treatment was not reported. The patient was not recovered from events. List of documents held by sender: none.
Patient admitted to hospital on 12/14/2021 Has UTI, fever 101.2, complaints of nausea and vomiting x2, generalized weakness  Denies other symptoms of COVID   Still admitted through 12/15/2021
On Monday morning I started feeling how my arm was getting swollen and red. I thought it was a normal reaction. At 7PM I felt like I was out of breath and someone was squeezing my heart. The next morning I went to a store to ask if this was a normal reaction and they told me to go to the ER. I went to the ER and they did an echocardiogram. Then I was admitted to the hospital. I was having so much pain in my chest. They did a bunch of heart tests and they said my heart was inflamed. They also provoked me a heart attack to see if everything was ok. I was 2 days at the hospital. They told me I could go home. They gave me Lisinopril and Aspirin. Yesterday I felt like a liquid running down  my armpit to my chest. My chest still hurts a lot.
arm was sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes mellitus" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN taken for diabetes mellitus. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm was sore".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt felt nauseous immediately after injection. Pt was observed and started to feel dizzy like passing out. I gave pt an ice pack and instructed pt to put head down. He began feeling better and after about 3 minutes his color came back and he felt much better. Pt was able to leave after observation on his own with no issues.
Patient states Fuzzy, light headed, head feel heavy like she wants to go to sleep. BP 156/78, reports she needs fresh air, feels claustrophobic. RN took the patient outside, took her mask off and started feeling better.  NO SOB no respiratory distress, denied pain. Patient education provided and instructed to call her PCP asap for appointment.
slight fever; body pains; arm soreness; feeling unwell; fast heartrate (97); This is a spontaneous report from contactable consumer (patient's friend). A 52-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 04Mar2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included ongoing asthma. The patient's concomitant medications were not reported. The patient experienced side effects such as (as reported) slight fever, body pains, arm soreness, feeling unwell and fast heartrate (97) on an unspecified date in Mar2021 (04Mar2021 or 05Mar2021). She spoke to her HCP regarding these side effects. The outcome of the events was unknown.  No follow-up attempts are Possible. Information on lot/batch cannot be obtained.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old male patient received BNT162b2 (BNT162B2), on 09Feb2021 at 14:00 as dose 1, single (Lot number: EL9267), in left arm, on 02Mar2021 at 14:00 as dose 2, single (Lot number: EN6202), in left arm and on 07Oct2021 at 13:00 as dose 3 (booster), single (Lot number: FF8841) at the age of 67 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "MGUS - lowest level of measurement" (unspecified if ongoing). Patient did not have any Known allergies. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. Treatment included Paxlovid from 09Jun2022 to 14Jun2022. Reporter stated, felt like the sinus portion of my covid infection came back for about 3 to five days beginning 20Jun2021. My initial covid symptoms had resolved by 18Jun2021. Patient did not receive other medication in 2 weeks.
Patient developed excessive sleepiness, headache, and unadjusted axillary temperature to 103.5 at home.
The pediatrician suggested a flu shot and dtap be given at the same time/same day one after the other. Days after, my baby started having seizures for the first time and has been diagnosed with epilepsy since and is still having seizures bith partial and IS. I believe both shots given on the same day cause my baby's seizures. I'm upset that the pediatrician even suggested it. My baby was a preemie born at 25 weeks which may have put him at risk of complications with the two given at the same time.
Within 5 minutes of the vaccine, patient had wheezing, shortness of breath and chest pain. patient given epi x 4, decadron, fluids with some improvement and then hospitalized. IN the hospital, patient continued to have chest pain and satting well but with protracted course and is still in the hospital.
significant light headedness; significant light headedness; little balance issue; mental fogginess; feel horrible; not feeling good; A spontaneous report was received from a health care professional(HCP) concerning a  46Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events Dizziness, Confusion state, Balance disorder, Feeling abnormal, Feeling abnormal,    The patient's medical history was not provided.  On 09-JAN-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch:025L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 10-JAN-2021, The patient experienced the events list significant light headedness, mental fogginess, little balance issue, feel horrible and not feeling good.   Laboratory details were not provided.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   On date, the outcome of the events significant light headedness was unknown,mental fogginess was unknown,little balance issue was unknown,feel horrible was unknown and not feeling good was unknown.   The reporter assessed the events significant light headedness,mental fogginess,little balance issue,feel horrible and not feeling good related to study drug is unknown.
A non-serious spontaneous report of administration of expired vaccine has been received form a registered nurse concerning a four-year-old female patient subsequent to FluMist. The patient's medical history and concomitant medications were not reported. On 25-Jan-2010, the patient was administered expired FluMist. There was no adverse event associated with this administration; therefore, treatment and reporter/ sponsor causality assessments are not applicable, and the event is considered resolved. This case is submitted in accordance with MedImmune's post-marketing commitment on accelerated reporting for the newly indicated population of 2 years to 59 month of age for FluMist.
Left rib area sharp pain, left hand and fingers sharp pain, left shoulder and neck sharp pain, shortness of breath and itching throughout Friday evening to and currently. Visit doctor's office Wednesday 11/11/15. I was prescribed HFA inhaler, 2 poofs twice/day, Prednisone 10mg, and hydroxyzine.
On 5/3/1990 he received the JEV dose #1 while on board ship. Three days later he developed a retro-orbital pressure headache, stiff neck, yellow skin and periumbilical pain. He was not on duty, so he went to bed. On 5/9/1990, 6 days post vaccine, his symptoms had worsened so that the eye pressure headache was 9-1/10; the stiff neck 5/10 with movement; the abdominal pain that radiated right and left was 5/10. The jaundice was worse; he developed myalgias so that he had bilateral popliteal pain and pain all over. He sought medical care and was admitted to the infirmary. By 5/9-12/1990, post vaccine day 6-9, his symptoms had all abated and he felt well. His diagnosis was Gilbert's Syndrome. Since that time he suffers similar episodes twice a year.
Parsonage-Turner Syndrome in right shoulder.  Severe pain in shoulder, neck, and upper arm.  Nerves in right shoulder not firing - feels paralyzed.  Weakness extends into arm and hand.  Still determining treatment options.  Pain has decreased to a manageable level as of today, but no improvement in nerves.
This spontaneous report was received from nurse. She reported that she inadvertently placed PROQUAD, which had lot # M031945 with expiry: 27-DEC-2017, in the refrigerator thinking it was M-M-R II because they were almost exactly identical each other. Additional information has been requested.
Within 4 mins of receiving vaccine pt became pale and diaphoretic and stated, "I think what you said it happening now but I am ok." Pt and mom waited remainder of recommended time after 2 mins and glass of water pt said, "It's gone now".
I63.81 ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 4/15/2023 ADENOCARCINOMA, HEAD OF PANCREAS
fever, muscle aches, sore throat, cough, headache, fatigue, diarrhea, congestion
Extreme irritability/fussiness, fever, sweats, crying in his sleep, inability to sleep, loss of appetite. Alternated Tylenol & Motrin every 3-4 hours for fever, and fever remained around 100.1 for over 24 hours.
pt recvd vax for prophylaxis; 24 hrs later, exp erythema, induration, swelling & cellulitis; was seen by MD; tx w/ rocephin & duricef;
Case number PHEH2015US020561 is an initial spontaneous report received from a nurse on 14 Oct 2015. This report refers to a patient of an unknown age and gender. Historical condition and concomitant medication were not provided. The patient was vaccinated with FLUVIRIN (batch number: not reported) intramuscularly in gluteal muscle on 10 Oct 2015. No adverse event was reported following this maladministration (vaccine administered at inappropriate site). The nurse stated she cannot provide any information on the case as per their privacy officer.
First dose on Jan 2021, no 2nd dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix  (received 1st dose in January 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 20-Sept-2022 Reporter's comment: The pharmacist stated that the patient's physician was the best person to make this decision whether to administer Shingrix late second dose or not. The reporter consented to follow-up via email. Additional supportive information: Till the time of reporting the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination.
Headache; fever; chills; nausea; vomiting; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 03Feb2021 15:45 at single dose in left arm for COVID-19 immunization. Medical history included allergies to Zithromax. Concomitant medication included topiramate. The patient previously received first dose of BNT162B2 on 13Jan2021 03:45 PM in left arm. The patient had no covid prior vaccination. The patient had no covid tested post vaccination. The patient experienced Headache, fever, chills, nausea, vomiting. Headache began about 2 hours after 2nd dosage administered (03Feb2021 17:45). Rest of symptoms began about 12 hours after headache. Vomiting, fever, chills and nausea all lasted about 8 to 10 hours. Headache lasted about 24 hour. No treatment was received for the events. The outcome of all events was resolved on 04Feb2021.  Information about lot/batch has been requested.
Information has been received from a registered nurse referring to a 4 month old patient of unknown gender. The patient's medical history, concurrent condition and concomitant medication were not reported. On an unknown date, the 4 months old patient was vaccinated with M-M-R II (rHA, 0.5 ml, lot # L026553, expiration date 16-JUL-2017) subcutaneously. No adverse effects were reported. Additional information has been requested.
lost my previous appetite and  smell after vaccination my cycle change lot and very pain during it, shortened menstrual cycle and chocolate color since vaccination my hair fall a lot my eye sight go down a lot  in very short time immunity becomes very weak and easy to get sick, easy to catch cold, and will keep coughing for a while as long as the back of body feels cold, it's hard to stop cough especially at night.
Pt had severe itching started shortly after 2nd shot. MD stated pt having histamine response and Atarax started 3x/day to control itching symptoms.  After several weeks pt stated atarax making her drowsy and requested to decrease to 2x/day. Pt started itching severely again after frequency decreased and pt requested to be put back to 3x/day. Shortly after pt had massive stroke which led to her death a couple of days later on 4/23/2021
became severely I'll from the preservatives in the shot/made me very sick; Initial information regarding an unsolicited valid non-serious case received on 13-Nov-2020 from a consume (Patient) via social media.  This case involved a patient of unknown age who became severely ill from the preservatives in the shot (Illness), while patient received vaccine INFLUENZA VACCINE.  Patient had a past vaccination with Influenza vaccine and got sick.  The patient's medical history, medical treatment, other vaccination details, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient became severely ill from the preservatives in the shot (illness) (Unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory tests reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for reported event.  There will be no information available on batch number for this case.
Dizziness FATIGUE, CHEST PAIN - SAME COMPLAINTS WITH 1ST AND 2ND VACCINE Narrative:
Muscle ache at injection site 4 hours after getting the shot. Full body aches (joints and muscles) 21 hours after injection (painful to move, sit upright and lay down). Pain level mostly tolerable but uncomfortable and required a pain reliever). Mild itchiness on injection arm.  Dry mouth, slightly sore throat.
Red warm area at site; 9/29/10 - headache fever (not take) 10.5 cm x 14cm red, hot local reaction. Temp in office was normal 9/30/10 - local reaction now itching.
Could not lift arm, site extremely heated, upper arm extremely sore to touch. Could not sleep,all night almost 2 nights.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 16Feb2021 as dose 2, single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "mild hypertension" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing); "known allergies: white fish" (unspecified if ongoing), notes: known allergies: white fish; "known allergies: jalapeno peppers" (unspecified if ongoing), notes: known allergies: jalapeno peppers; "Allergy: sulfa" (unspecified if ongoing), notes: Allergy: sulfa. The patient took concomitant medications. Past drug history included: Emycin, reaction(s): "Allergy: Emycin"; Betadine, reaction(s): "Allergy: betadine". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 20Jul2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Indication: Covid-19 treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient received other medication in 2 weeks of vaccine. Anti viral details included COVID 19 Treatment, brand was Paxlovid, started on 11Jul2022 to 16Jul2022, lot number was 00069-1085-30.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt developed fever 102, chills and body aches evening of vaccine. Mon am (2/1/2021) awoke with chest pain. Came to ED for evaluation, diffuse ST elevation in all leads, troponin elevated 4.1, 2nd trop 33.   echocardiogram with EF 50%  pt currently being worked up for pericarditis, ACS with plans for heart cath in am
No signes or symptons within the first 20 days from when vaccinated.  On the 21st day, New Year 's Eve Day, pt. had an appoint to have a heart monitor fitted at the Hospital.  On the way I observed the color drain from his face.  I touched his forehead it felt hot.  He said he didn't feel well but felt he was obligated to keep the appointment.  Within the hour from when he entered the hospital, he had thrown up, passed out and transported to the Emergency Room.  A heart attack was ruled out and he was admitted to the hospital for further treatment and discovery of Pnemonia in the Blood. Ventoline HFA. Has he recovered from the adverse event?  the question cannot be answered with a simple yes or no.  Yes they did get rid of the Pnomonia in the Blood, but is our argument that event was the beginning of a deliberating disease of Belle Palsey, which actually began in the hospital while being  treated for Pneumonia, beginning with a severe, persistent pain on the right side of his head. He suffered an acute case of praylysisi on the right side of his face which caused drooping of the mouth, inability to chew properly, his right eye ceased to blink properly, causing painful dry eye condiition and his vision ihas worsened over time.
Pt recvd 2nd dose of Hep B & two wks following vax, pt exp transverse myelitis;
Joint pain/ shoulders/ hip; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain/ shoulders/ hip) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free, Solution for injection in pre-filled pen. On an unknown date, the patient experienced ARTHRALGIA (Joint pain/ shoulders/ hip). At the time of the report, ARTHRALGIA (Joint pain/ shoulders/ hip) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       No concomitant medications information was reported. It was unknown if the patient was enrolled in a COVID-19 Vaccine Trial. No treatment medications were provided.
She developed diffuse warts over lower body, buttock and right arm after the third HPV vaccine.
Patient went to ER due to confusion dizziness, chills & fever Patient was admitted to Medical Center for hyperthermia, heat stroke, sepsis